Boehringer Ingelheim and Zai Lab launch a clinical collaboration to evaluate a dual DLL3‑targeting combination therapy in small cell lung cancer (SCLC) and other neuroendocrine carcinomas (NECs).

The potential of STAR-LLD to improve lenalidomide’s therapeutic index suggests an opportunity for use in combination with CAR-T cell therapies. As described in the patent application, STAR-LLD's ...

Discover how to turn creative ideas into stunning visuals with invideo AI, followed by a detailed step-by-step tutorial on making your own combination lock from metal. This video explores both the ...

Abstract: Drug combination synergy is crucial in pharmacology, as it can enhance disease treatment efficacy or reduce drug resistance when administered in combination. Accurate prediction of drug ...

COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) today announced new results from the Phase 1b/2 EPCORE ® NHL-2 trial Arm 10 (NCT04663347), evaluating epcoritamab, a T-cell engaging ...

Three-year and five-year outcomes of a phase II study of perioperative CapeOx therapy for advanced gastric cancer with extensive lymph node metastasis (OGSG1701). This is an ASCO Meeting Abstract from ...

Many states and school districts now ban or restrict the use of cell phones in schools. But what do the kids think about this? Student journalists in New Jersey brought this question to their ...

Berlin, Germany, Nov. 14, 2025 (GLOBE NEWSWIRE) -- think-cell proudly announces the launch of a new version of their flagship PowerPoint productivity software, think-cell Suite. The latest upgrade, ...